
LumiraDx Limited
Aktie · KYG5709L1095 · LMDX (XNAS)
Kein Kurs
n/a
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
- | - | - | - | 0,00 % | 0,00 % | -99,85 % |
Company Profile for LumiraDx Limited Share
LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has approximately 30 tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions from the lab to point of need. Its diagnostic testing solutions are deployed by governments and healthcare institutions across laboratories, urgent care, physician offices, pharmacies, schools, and workplaces to screen, diagnose, and monitor wellness, as well as disease. The company was founded in 2014 and is headquartered in London, the United Kingdom.
Company Data
Name LumiraDx Limited
Company LumiraDx Limited
Symbol LMDX
Website
https://www.lumiradx.com
Primary Exchange
NASDAQ

ISIN KYG5709L1095
Asset Class Share
Sector Healthcare
Industry Medical - Diagnostics & Research
CEO Ms. Veronique Ameye EMBA, Esq., M.B.A.
Country United Kingdom
Currency USD
Employees 1,2 T
Address 3 More London Riverside, SE1 2AQ London
IPO Date 2021-03-19
Ticker Symbols
Name | Symbol |
---|---|
NASDAQ | LMDX |
More Shares
Investors who LumiraDx Limited hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.